Lataa...
MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53
Glioblastoma multiforme is the most common primary malignancy in the brain and confers a uniformly poor prognosis. MicroRNAs have been shown to activate or inhibit tumorigenesis. Abnormalities in the p53 signaling pathway are found in various cancers and correlate with tumor formation. We examined t...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642619/ https://ncbi.nlm.nih.gov/pubmed/29050344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20528 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|